Adis International Ltd.

SHERPA: Unknown

People

  1. Hahn
    Hahn
  2. Mitchell
    Mitchell
  3. Stein
    Stein
  4. Zauber
    Zauber

Groups

  1. Department of Medicine (2)
  2. Epidemiology and Biostatistics (2)
  3. Population Sciences Research Program (2)
  4. Sloan Kettering Institute Postdocs (2)
  5. Adult Leukemia (1)
  6. Center for Hematologic Malignancies (1)
  7. Epidemiology Service (1)
  8. Genitourinary Oncology Service (1)
  9. Health Outcomes Research Group (1)
  10. Hematologic Malignancies, Division of (1)
Search Within
Formats
  1. Journal Article (4)
  2. Review (1)
Groups
  1. Department of Medicine (2)
  2. Epidemiology and Biostatistics (2)
  3. Population Sciences Research Program (2)
  4. Sloan Kettering Institute Postdocs (2)
  5. Adult Leukemia (1)
  6. Center for Hematologic Malignancies (1)

More Groups

People
  1. Andrew Briggs (2)
  2. Aaron Mitchell (1)
  3. Ann Zauber (1)
  4. Anne Hahn (1)
  5. Eytan Stein (1)
  6. Jennifer Ohn (1)

More People

Years
  1. 2023 (1)
  2. 2020 (1)
  3. 2019 (2)
  4. 2018 (1)
Publications
  1. PharmacoEconomics (5)

Results (5)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Critical appraisal of decision models used for the economic evaluation of bladder cancer screening and diagnosis: A systematic review
    Review

    Mandrik, O.; Hahn, A. I.; Catto, J. W. F.; Zauber, A. G.; Cumberbatch, M.; Chilcott, J.
    PharmacoEconomics (2023)

    Fulltext@MSK | Save
  • The accuracy and usefulness of the National Comprehensive Cancer Network Evidence Blocks Affordability rating
    Journal Article

    Mitchell, A. P.; Dey, P.; Ohn, J. A.; Tabatabai, S. M.; Curry, M. A.; Bach, P. B.
    PharmacoEconomics (2020)

    Fulltext@MSK | Save
  • Estimating lifetime benefits associated with immuno-oncology therapies: Challenges and approaches for overall survival extrapolations
    Journal Article

    Ouwens, M. J. N. M.; Mukhopadhyay, P.; Zhang, Y.; Huang, M.; Latimer, N.; Briggs, A.
    PharmacoEconomics (2019)

    Fulltext@MSK | Save
  • Cost effectiveness of midostaurin in the treatment of newly diagnosed FLT3-mutated acute myeloid leukemia in the United States
    Journal Article

    Stein, E.; Xie, J.; Duchesneau, E.; Bhattacharyya, S.; Vudumula, U.; Ndife, B.; Bonifacio, G.; Guerin, A.; Li, N.; Joseph, G.
    PharmacoEconomics (2019)

    Fulltext@MSK | Save
  • Probabilistic sensitivity analysis in cost-effectiveness models: Determining model convergence in cohort models
    Journal Article

    Hatswell, A. J.; Bullement, A.; Briggs, A.; Paulden, M.; Stevenson, M. D.
    PharmacoEconomics (2018)

    Fulltext@MSK | Save

    • Adis International Ltd. – authorized name for: